Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
0 hedge funds and large institutions have $0 invested in Vaxxinity, Inc. Class A Common Stock in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $31 → $0 (-$31)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NS
NBC Securities
Birmingham,
Alabama
|
-$31 |
VAXX Hedge Fund Activity: Q4 2025 in Review
0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q4 2025, worth a combined $0 — down 100% from $31 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VAXX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was NBC Securities, exiting entirely with an estimated $31 sold.
- 0 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q4 2025, down from 1 in Q3 2025.
- Funds reported $0 of Vaxxinity, Inc. Class A Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q4 2025 was NBC Securities, an estimated $31 sold.
Based on aggregated 13F filings for Q4 2025.